Neurogene Inc. - 8-K Filing
Neurogene Inc. filed to report the results of its 2026 Annual Meeting of Stockholders held on June 3, 2026. Shareholders elected directors Robert Baffi and Rohan Palekar with over 84% approval each; approved executive compensation advisory vote with ~97% in favor; ratified Deloitte & Touche LLP as auditors with ~81% support; and voted to hold future advisory votes on executive pay annually, receiving nearly 99.5% backing.
Tickers: $NGNE